Scienture Holdings, Inc. Files Q3 2024 Report

Ticker: SCNX · Form: 10-Q · Filed: Nov 6, 2024 · CIK: 1382574

Scienture Holdings, Inc. 10-Q Filing Summary
FieldDetail
CompanyScienture Holdings, Inc. (SCNX)
Form Type10-Q
Filed DateNov 6, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$0.00001
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, sec-filing

Related Tickers: SCNX

TL;DR

**SCNX Q3 filing out. All good on reporting.**

AI Summary

Scienture Holdings, Inc. (formerly TRxADE HEALTH, INC.) filed its quarterly report for the period ending September 30, 2024. The company's common stock trades under the symbol SCNX on The NASDAQ Stock Market LLC. The filing indicates the company has met its reporting requirements for the preceding 12 months and the past 90 days.

Why It Matters

This filing provides investors with an update on Scienture Holdings, Inc.'s financial performance and operational status for the third quarter of 2024.

Risk Assessment

Risk Level: low — The filing is a standard quarterly report and does not contain immediate red flags or significant negative disclosures.

Key Players & Entities

  • Scienture Holdings, Inc. (company) — Registrant
  • TRxADE HEALTH, INC. (company) — Former name
  • September 30, 2024 (date) — Quarterly Period End Date
  • SCNX (company) — Trading Symbol
  • The NASDAQ Stock Market LLC (company) — Exchange

FAQ

What is the trading symbol for Scienture Holdings, Inc. common stock?

The trading symbol for Scienture Holdings, Inc. common stock is SCNX.

On which exchange is Scienture Holdings, Inc. common stock listed?

Scienture Holdings, Inc. common stock is listed on The NASDAQ Stock Market LLC (The NASDAQ Capital Market).

What was the former name of Scienture Holdings, Inc.?

The former name of Scienture Holdings, Inc. was TRxADE HEALTH, INC.

For what period is this quarterly report filed?

This quarterly report is filed for the period ended September 30, 2024.

Has Scienture Holdings, Inc. filed all required reports for the preceding 12 months?

Yes, the filing indicates that the registrant has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months.

Filing Stats: 4,736 words · 19 min read · ~16 pages · Grade level 15.3 · Accepted 2024-11-06 08:06:01

Key Financial Figures

  • $0.00001 — nge on which registered Common Stock, $0.00001 Par Value Per Share SCNX The NASDAQ

Filing Documents

: FINANCIAL INFORMATION

PART I: FINANCIAL INFORMATION 4

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS 4

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 29

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 37

CONTROLS AND PROCEDURES

ITEM 4. CONTROLS AND PROCEDURES 37

OTHER INFORMATION

PART II. OTHER INFORMATION 39

LEGAL PROCEEDINGS

ITEM 1. LEGAL PROCEEDINGS 39

RISK FACTORS

ITEM 1A. RISK FACTORS 39

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 40

DEFAULTS UPON SENIOR SECURITIES

ITEM 3. DEFAULTS UPON SENIOR SECURITIES 40

MINE SAFETY DISCLOSURES

ITEM 4. MINE SAFETY DISCLOSURES 40

OTHER INFORMATION

ITEM 5. OTHER INFORMATION 40

EXHIBITS

ITEM 6. EXHIBITS 41 2 Table of Contents CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q (" Report "), including without limitation, " Management's Discussion and Analysis of Financial Condition and Results of Operations, " contains forward-looking statements, within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, regarding future events and the future results of Scienture Holdings, Inc. (f/k/a TRxADE Health, Inc.) (the " Company ") that are based on current expectations, estimates, forecasts, and projections about the industry in which the Company operates and the beliefs and assumptions of the management of the Company. Words such as " expects, " " anticipates, " " targets, " " goals, " " projects, " " intends, " " plans, " " believes, " " seeks, " " estimates, " variations of such words, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are only predictions and are subject to risks, uncertainties and assumptions that are difficult to predict. These factors include, but are not limited to: Our limited amount of cash; The negative effect on our business and our ability to raise capital that is created by the fact that there is a substantial doubt about our ability to continue as a going concern; Risks of our operations not being profitable; Claims relating to alleged violations of intellectual property rights of others; Technical problems with our websites; Cybersecurity risks; Risks relating to implementing our acquisition strategies, and, risks related to our ability to integrate the business operations of businesses that we acquire from time to time ; Negative effects on our operations associated with the opioid pain medication health crisis; Regulatory and licensing requirement risks; Risks related to changes in the U.S. healthcare environment; The status of our informa

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.